Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.

Ryu JS, Ryu HJ, Lee SN, Memon A, Lee SK, Nam HS, Kim HJ, Lee KH, Cho JH, Hwang SS.

J Clin Oncol. 2014 Mar 20;32(9):960-7. doi: 10.1200/JCO.2013.50.5453.

PMID:
24550423
2.

Minimal Pleural Effusion in Small Cell Lung Cancer: Proportion, Mechanisms, and Prognostic Effect.

Ryu JS, Lim JH, Lee JM, Kim WC, Lee KH, Memon A, Lee SK, Yi BR, Kim HJ, Hwang SS.

Radiology. 2016 Feb;278(2):593-600. doi: 10.1148/radiol.2015142388.

PMID:
26323029
3.

Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.

Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R.

J Thorac Oncol. 2012 Oct;7(10):1485-9. doi: 10.1097/JTO.0b013e318267223a.

4.

The role of CT pulmonary angiography in the investigation of unilateral pleural effusions.

Hooper C, Laurence I, Harvey J, Morley A, Darby M, Edey A, Maskell N.

Respiration. 2014;87(1):26-31. doi: 10.1159/000347003.

PMID:
23816819
5.

Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.

Nakao M, Hoshi R, Ishikawa Y, Matsuura Y, Uehara H, Mun M, Nakagawa K, Okumura S.

Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):777-82. doi: 10.1093/icvts/ivv047.

PMID:
25762707
6.

Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.

Ren S, Terman DS, Bohach G, Silvers A, Hansen C, Colt H, Sahn SA.

Chest. 2004 Nov;126(5):1529-39. Erratum in: Chest. 2011 Sep;140(3):835.

PMID:
15539723
7.

Prognostic value of pleural effusion in patients with non-small cell lung cancer.

Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K.

Clin Cancer Res. 1997 Jan;3(1):47-50.

8.

Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion.

Duysinx B, Corhay JL, Larock MP, Nguyen D, Bury T, Hustinx R, Louis R.

Nucl Med Commun. 2008 Nov;29(11):982-6. doi: 10.1097/MNM.0b013e32830978c4.

PMID:
18836376
9.

Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.

Yamaguchi M, Ichinose Y, Shimamatsu S, Yoshida T, Toyokawa G, Nosaki K, Hirai F, Seto T, Takenoyama M.

Surg Oncol. 2015 Jun;24(2):78-83. doi: 10.1016/j.suronc.2015.02.004.

PMID:
25818753
10.

In lung cancer patients where a malignant pleural effusion is found at operation could resection ever still be justified?

Fiorelli A, Santini M.

Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):407-12. doi: 10.1093/icvts/ivt153. Review.

11.

Important prognostic factors for survival in patients with malignant pleural effusion.

Zamboni MM, da Silva CT Jr, Baretta R, Cunha ET, Cardoso GP.

BMC Pulm Med. 2015 Mar 28;15:29. doi: 10.1186/s12890-015-0025-z.

12.

Pleural dissemination in non-small cell lung cancer: results of radiological evaluation and surgical treatment.

Akaogi E, Mitsui K, Onizuka M, Ishikawa S, Tsukada H, Mitsui T.

J Surg Oncol. 1994 Sep;57(1):33-9.

PMID:
8065151
13.

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, Russell A, Komaki R, Lee JS.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1475-82.

PMID:
11121651
14.

Transoesophageal endoscopic ultrasound-guided fine-needle aspiration of pleural effusion for the staging of non-small cell lung cancer.

Lococo F, Cesario A, Attili F, Chiappetta M, Leuzzi G, Costamagna G, Granone P, Larghi A.

Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):237-41. doi: 10.1093/icvts/ivt166.

15.

[Thoracocentesis for the assessment of lung cancer with pleural effusion].

Martín Díaz E, Arnau Obrer A, Martorell Cebollada M, Cantó Armengod A.

Arch Bronconeumol. 2002 Oct;38(10):479-84. Spanish.

16.
17.

Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.

Kim BS, Kim IJ, Kim SJ, Pak K, Kim K.

Onkologie. 2011;34(6):298-303. doi: 10.1159/000328793.

PMID:
21625182
18.

Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.

Hsu IL, Su WC, Yan JJ, Chang JM, Lai WW.

Lung Cancer. 2009 Sep;65(3):371-6. doi: 10.1016/j.lungcan.2008.12.007.

PMID:
19157636
19.

Pleural effusion as a significant prognostic factor in non-small cell lung cancer.

Naito T, Satoh H, Ishikawa H, Yamashita YT, Kamma H, Takahashi H, Ohtsuka M, Hasegawa S.

Anticancer Res. 1997 Nov-Dec;17(6D):4743-6.

PMID:
9494600

Supplemental Content

Support Center